Results: 29

Tratamiento de Helicobacter pylori para la prevención de cáncer gástrico metacrónico

Gastroenterol. latinoam; 29 (3), 2018

Tratamento antissecretor da doença do refluxo gastroesofágico pediátrica - uma revisão sistemática

Arq. gastroenterol; 54 (4), 2017
ABSTRACT BACKGROUND: Proton pump inhibitors and histamine H2 receptor antagonists are two of the most commonly prescribed drug classes for pediatric gastroesophageal reflux disease, but their efficacy is controversial. Many patients are treated with these drugs for atypical manifestations attributed to...

Edema de Reinke obstructivo
Obstructive Reinke edema

Introducción: el edema de Reinke es la acumulación de fluidos en la capa externa de la lámina propia de las cuerdas vocales. Produce disfonía y raras veces obstrucción respiratoria. Las etiologías más frecuentes son el tabaquismo, el reflujo gastroesofágico y el mal uso y abuso vocal. Objetivos: ...

Efectividad de un nuevo régimen simplificado en la erradicación de Helicobacter pylori. Estudio prospectivo realizado en una clínica privada de Lima Metropolitana

RESUMEN Objetivo: Determinar la efectividad de dos nuevos esquemas para el tratamiento de Helicobacter pylori frente al esquema triple convencional de amoxilina, claritromicina y un inhibidor de bomba de protones. Materiales y métodos: Estudio prospectivo, no aleatorio, realizado en una clínica privada...

Eficacia de terapia concomitante sin bismuto en la erradicación de Helicobacter pylori en Chile: estudio prospectivo

Gastroenterol. latinoam; 28 (3), 2017
Standard triple therapy (TT), used massively as first-line empirical therapy for Helicobacter pylori (H. pylori) eradication, has shown a progressive decrease in its effectiveness, probably due to increasing resistance to clarithromycin. Recent studies in Chile show eradication under 90%, a limit suggest...

Rol del manejo dietario y farmacológico en la esofagitis eosinofílica

Gastroenterol. latinoam; 28 (supl.1), 2017
Eosinophilic esophagitis is an inflammation of the esophagus, causing dysfunction and fibrosis. Dysphagia or food impaction are common symptoms, that do not respond to proton pump inhibitors. Initial management must include an evaluation for food allergies .Emerging data in adults suggest that the elimin...

DRGE não responsiva a IBP: qual a conduta?
GERD not responsive to IBP: what is the conduct?

J. bras. med; 103 (2), 2016
Os inibidores da bomba de prótons (IBPs) são os fármacos mais utilizados no tratamento da doença do refluxo gastroesofágico (DRGE). Apesar de não reduzirem expressivamente o número de episódios de refluxo, propiciam mudança significativa na acidez. Isso quer dizer que continua havendo refluxo, p...

Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux

Braz. j. med. biol. res; 49 (7), 2016
The objective of this study was to perform a systematic review and meta-analysis to assess the effectiveness of proton pump inhibitors (PPI) for reflux disease in adult patients with laryngopharyngeal symptoms. A comprehensive search of Cochrane Library, EMBASE, Ovid EBM Reviews, and PubMed was performed...

Esophagectomy with gastroplasty in advanced megaesophagus: late results of omeprazole use

Rev. Col. Bras. Cir; 42 (5), 2015
Objective: To analyze the late results of advanced Chagasic megaesophagus treatment by esophagectomy associated with the use of proton pump inhibitor (omeprazole) as for the incidence of esophagitis and Barrett's esophagus in the remaining stump. Methods : We studied patients with advanced megaesophagus ...